Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: West Pharmaceutical Services | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: West Pharmaceutical Services

Revenues up 8% in the quarter led by growth in the Pharma Market Unit

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

West Pharmaceutical Services
3Q Revenues: $431.7 million (+8%)
3Q Earnings: $55.2 million (+8%)
YTD Revenues: $1.3 billion (+9%)
YTD Earnings: $154.9 million (+3%)
Comments: Proprietary Products segment sales were $325.2 million in the quarter, up 5% led by double-digit growth in the Pharma Market Unit. Contract manufactured product sales were $106.7 million, up 19% driven by continued demand for diabetes-related diagnostic and drug delivery devices. Biologics sales were impacted by a decline in self-injection delivery device sales associated with lower than expected commercial sales of the underlying drug product.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters